Saving lives, one vaccine at a time.

We are developing a whole new way to deliver vaccines. Vaccines that are safe, shelf-stable, and come at a low cost are ideal for saving lives. We are tackling some of the toughest pathogens on the planet, starting with Pseudomonas aeruginosa, an important opportunistic human pathogen that causes serious infections in patients with cystic fibrosis, burns, severe wounds, pneumonia, and critically ill patients who require intubation or catheterization. Additionally, P. aeruginosa is a major cause of combat-related wound infections that are difficult to treat due to high antibiotic resistance and associated with high morbidity. Yet, there is no vaccine.